[1] Tartaglia M, Gelb BD. Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. Ann N Y Acad Sci. 2010;1214:99-121.
[2] Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab. 2011;25:161-179.
[3] Gripp KW, Morse LA, Axelrad M, Chatfield KC, Chidekel A, Dobyns W, et al. Costello syndrome: Clinical phenotype, genotype, and management guidelines. Am J Med Genet A. 2019;179:1725-1744.
[4] Pierpont ME, Magoulas PL, Adi S, Kavamura MI, Neri G, Noonan J, et al. Cardio-facio cutaneous syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2014;134:e1149-e1162.
[5] Stevenson DA, Yang FC. The musculoskeletal phenotype of the RASopathies. Am J Med Genet C Semin Med Genet. 2011;157:90-103.
[6] Rhodes SD, Zhang W, Yang D, Yang H, Chen S, Wu X et al. Dystrophic spinal deformities in a neurofibromatosis type 1 murine model. PLoS One. 2015;10:e0119093.
[7] Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017;3:17004.
[8] Yassir WK, Grottkau BE, Goldberg MJ. Costello syndrome: orthopaedic manifestations and functional health. J Pediatr Orthop. 2003;23:94-98.
[9] White SM, Graham JM, Jr, Kerr B, Gripp K, Weksberg R, Cytrynbaum C, et al. The adult phenotype in Costello syndrome. Am J Med Genet A. 2005;136:128-135.
[10] Armour CM, Allanson JE. Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations. J Med Genet. 2008;45:249-254.
[11] Reinker KA, Stevenson DA e Tsung A. Orthopaedic conditions in Ras/MAPK related disorders. J Pediatr Orthop. 2011;31:599-605.
[12] Stevenson DA, Allen S, Tidyman WE, Carey JC, Viskochil DH, Stevens A et al. Peripheral muscle weakness in RASopathies. Muscle Nerve. 2012;46:394-399.
[13] Detweiler S, Thacker MM, Hopkins E, Conway L, Gripp KW. Orthopedic manifestations and implications for individuals with Costello syndrome. Am J Med Genet Part A. 2013;161:1940-1949.
[14] Stevenson DA, Schill L, Schoyer L, Andresen BS, Bakker A, Bayrak-Toydemir P et al. The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway. Am J Med Genet A. 2016; 170:1959.
[15] Johnson B, Goldberg-Strassler D, Gripp K, Thacker M, Leoni C, Stevenson D. Function and disability in children with Costello syndrome and Cardiofaciocutaneous syndrome. Am J Med Genet A. 2014;167:40-44.
[16] Axelrad ME, Schwartz DD, Katzenstein JM, Hopkins E, Gripp KW. Neurocognitive, adaptive and behavioral functioning of individuals with Costello syndrome: a review. Am J Med Genet C Semin Med Genet. 2011;157:115-122.
[17] American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-117.
[18] Daltroy LH, Liang MH, Fossel AH, Goldberg MJ. The POSNA pediatric musculoskeletal functional health questionnaire: report on reliability, validity, and sensitivity to change. Pediatric Outcomes Instrument Development Group. Pediatric Orthopaedic Society of North America. J Pediatr Orthop. 1998;18:561-571.
[19] Haynes RJ and Sullivan E. The Pediatric Orthopaedic Society of North America pediatric orthopaedic functional health questionnaire: an analysis of normal. J Pediatr Orthop. 2001;21:619621.
[20] Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer V, et al. Six-minute walk test in children and adolescents. J Pediatr. 2007;150:395-9.
[21] Jenkins S, Cecins N, Camarri B, Williams C, Thompson P, Eastwood P. Regression equations to predict 6-minute walk distance in middle-aged and elderly adults. Physiother Theory Pract. 2009;25:516-522.
[22] Leoni C, Giorgio V, Onesimo R, Kuczynska E, Zampino G. Impact of Costello syndrome on growth patterns. Am J Med Genet Part A. 2020; doi: 10.1002/ajmg.a.61812
[23] Tidyman WE, Lee HS e Rauen KA. Skeletal muscle pathology in Costello and Cardio-Facio Cutaneous Syndromes: developmental consequences of germline Ras/MAPK activation on myogenesis. Am J Med Genet Part C. 2011;157:104-114.
[24] Jo C, Jang BG, Jo SA. MEK1 plays contrary stage-specific roles in skeletal myogenic differentiation. Cell Signal. 2009;21:1910-1917.
[25] Leoni C, Triumbari EKA, Vollono C, Onesimo R, Podagrosi M, Giorgio V, et al. Pain in individuals with RASopathies: Prevalence and clinical characterization in a sample of 80 affected patients. Am J Med Genet A. 2019;179:940-947.
[26] Alfieri P, Piccini G, Caciolo C, Perrino F, Gambardella ML, Mallardi M, et al. Behavioral profile in RASopathies. Am J Med Genet A. 2014;164:934-942.
[27] Yoon G, Rosenberg J, Blaser S, Rauen KA. Neurological complications of cardio-facio cutaneous syndrome. Dev Med Child Neurol. 2007;49:894-899.
[28] Dileone M, Zampino G, Profice P, Pilato F, Leoni C, Ranieri F et al. Dystonia in Costello syndrome. Parkinsonism Relat Disord. 2012;18:798-800.
[29] Leoni C, Stevenson DA, Martini L, De Sanctis R, Mascolo G, Pantaleoni F, et al. Decreased bone mineral density in Costello syndrome. Mol Genet Metab. 2014;111:41-45.